
Biostat Research and Development sp. z o.o.
Research and experimental development on biotechnology
Overview
Biostat Research And Development is a Contract Research Organization (CRO) that conducts clinical trials and statistical analyses in various medical fields, including oncology, nephrology, and immunology. The company specializes in observational studies and non-interventional studies to assess treatment outcomes and efficacy for conditions such as systemic lupus erythematosus and multiple myeloma. Additionally, they provide software solutions and market research services for the medical sector.
Financials
Revenue history (in k)
From the notes
| Profit allocation | No decision |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 81 days late).
- 202512/07/2026
- 202411/07/2025
- 202308/07/2024
- 202205/07/2023
- 202104/10/2022
- 202001/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical trials
- Statistical analysis
- Market research
- Public opinion research
- eCRF software
- Research project support
Websites
- biostat.com.plBiostat® – kompleksowe CRO | badania kliniczne | statystyka | analizyGoogle AnalyticsGoogle Tag ManagerNginx
Public procurement
No recorded participation in tenders.
The company is the contractor in one public sector contract, worth USD 2.16k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 7, 2026 | Quantitative research service | $2,161 | Uniwersytet Jagielloński Collegium Medicum |
Job offers
The company lists 40 job openings on its own careers page: biostat.com.pl/kariera.
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mer Fundacja Rodzinna | 50 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Biostat Research and Development.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $55,670.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oncotarget Wojciech Jurczak S.K.A. | $192,291.27 | oncotarget.pl | ||
| Monipol Biotech Pl sp. z o.o. | $191,735.74 | monipol-biotech.com | ||
| GCP-Service International Ltd. & Co. Kg Branch (foreign co.) | $159,376.34 | gcp-service.com | ||
| Pharmaxi Poland sp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| HTA Registry sp. z o.o. | $96,615.01 | htaregistry.pl | ||
| Quantum Satis sp. z o.o. | $82,346.73 | quantumsatis.pl | ||
| Prophase sp. z o.o. | $80,481.99 | prophase.eu | ||
| Medapp Clinical Research sp. z o.o. | $55,499.75 | medappclinicalresearch.pl | ||
| Zawamed sp. z o.o. | $43,909.06 | zawamed.pl | ||
| Excelya Poland sp. z o.o. | $14,377.54 | excelya.com |
FAQ
Last updated: 2026-10-07
